tiprankstipranks
X4 Pharmaceuticals announces $125M capital infusion
PremiumThe FlyX4 Pharmaceuticals announces $125M capital infusion
3M ago
Hercules Capital price target raised to $21.50 from $21 at Piper Sandler
PremiumThe Fly
Hercules Capital price target raised to $21.50 from $21 at Piper Sandler
3M ago
Hercules Capital price target raised to $21 from $19 at Ladenburg
PremiumThe Fly
Hercules Capital price target raised to $21 from $19 at Ladenburg
3M ago
Hercules Capital price target raised to $19 from $18 at JMP Securities
PremiumThe FlyHercules Capital price target raised to $19 from $18 at JMP Securities
4M ago
Bluebird Bio price target lowered to $1.68 from $3 at Wedbush
PremiumThe Fly
Bluebird Bio price target lowered to $1.68 from $3 at Wedbush
4M ago
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
5M ago
HTGC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsHTGC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5M ago
Hercules Capital downgraded to Neutral from Buy at Compass Point
PremiumThe Fly
Hercules Capital downgraded to Neutral from Buy at Compass Point
6M ago
Phathom expands existing loan, security agreement with Hercules Capital
PremiumThe Fly
Phathom expands existing loan, security agreement with Hercules Capital
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100